Castle Biosciences (CSTL) Income from Continuing Operations (2018 - 2026)
Castle Biosciences (CSTL) posted Income from Continuing Operations of 14522000.0 for Q1 2026, down 522.73% sequentially from 2332000.0 in Q4 2025, and up 43.82% YoY from 10097505.14 in Q1 2025.
Castle Biosciences (CSTL) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Castle Biosciences (CSTL) has 9 years of Income from Continuing Operations data on file, last reported at 14522000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 43.82% year-over-year to 14522000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12832000.0 (down 153.15% YoY) and the FY2025 annual result came in at 24158000.0, down 232.41% from the prior year.
- Income from Continuing Operations eased to 14522000.0 in Q1 2026 per CSTL's latest filing, from 2332000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 9590000.0 in Q4 2024, with the low at 29204000.0 in Q1 2023.
- Average Income from Continuing Operations over 5 years is 8531705.88, with a median of 2580000.0 recorded in 2023.
- Year-over-year, Income from Continuing Operations plunged 1039.38% in 2023 and jumped 471.71% in 2024.
- Castle Biosciences' Income from Continuing Operations stood at 20618000.0 in 2022, then surged by 87.49% to 2580000.0 in 2023, then jumped by 471.71% to 9590000.0 in 2024, then slumped by 124.32% to 2332000.0 in 2025, then slumped by 522.73% to 14522000.0 in 2026.
- Business Quant data shows CSTL's Income from Continuing Operations at 14522000.0 in Q1 2026, 2332000.0 in Q4 2025, and 501000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Castle Biosciences | 738.56 Mn | 476.84 Mn | 63.15 Mn | -14.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.52 Mn |
| Dec 31, 2025 | -2.33 Mn |
| Sep 30, 2025 | -501,000.00 |
| Jun 30, 2025 | 4.52 Mn |
| Mar 31, 2025 | -25.85 Mn |
| Dec 31, 2024 | 9.59 Mn |
| Sep 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 8.92 Mn |
| Mar 31, 2024 | -2.53 Mn |
| Dec 31, 2023 | -2.58 Mn |
| Sep 30, 2023 | -6.91 Mn |
| Jun 30, 2023 | -18.78 Mn |
| Mar 31, 2023 | -29.20 Mn |
| Dec 31, 2022 | -20.62 Mn |
| Sep 30, 2022 | -20.25 Mn |
| Jun 30, 2022 | -1.65 Mn |
| Mar 31, 2022 | -24.62 Mn |
| Dec 31, 2021 | -13.38 Mn |
| Sep 30, 2021 | -11.79 Mn |
| Jun 30, 2021 | -8.79 Mn |